APP and early-onset autosomal dominant Alzheimer disease: In overall, these results suggest that Ngfr signaling reduces amyloid and Tau pathology concomitant to enhancing adult hippocampal neurogenesis in APP/PS1dE9 mouse model of Alzheimer’s disease.